Nanolek, GEROPHARM, Generium, Acticomp, Polysan, Petrovax Pharm, BIOCAD, ChemRar, Pharmstandard and Association of Pharmaceutical Manufacturers of the EAEU
Signing of the Declaration on the policy in the field of development, production and quality control of medicines by the companies – participants in the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union.
The Declaration is an important step in the comprehensive work to improve an open and constructive dialogue with the medical and patient communities. Its main goal is to increase the confidence of patients and doctors in the quality of Russian medicines. To this end, manufacturing companies of medicines and pharmaceutical substances are publicly taking on increased obligations to promote the implementation of a patient-centered approach in the healthcare system at all stages of the life cycle of medicines.
Representatives of the parties signing the agreement
Sergey Glagolev, Deputy Minister of Health of the Russian Federation
Yuriy Zhulev, President, Russian Hemophilia Society; Co-Chair, Russian Patients Association
Andrey Ivaschenko, Chairman of the Board, ChemRar
Dmitry Kudlay, Vice President for implementation of new medical technologies, GENERIUM
Stanislav Naumov, Chairman of the Board, Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU)
Vasily Osmakov, First Deputy Minister of Industry and Trade of the Russian Federation
Petr Rodionov, General Director, GEROPHARM
Alexander Semenov, President, ACTICOMP
Maxim Stetsyuk, Executive Director, Member of the Board, NANOLEK
Mikhail Tsyferov, President, Petrovax